Pharma-Bio Serv (PBSV) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to -$0.01.
- Pharma-Bio Serv's EPS (Weighted Average and Diluted) rose 8840.58% to -$0.01 in Q4 2025 from the same period last year, while for Oct 2025 it was $0.0, marking a year-over-year increase of 10657.89%. This contributed to the annual value of -$0.0 for FY2025, which is 8823.53% up from last year.
- Per Pharma-Bio Serv's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.01 for Q4 2025, which was up 8840.58% from $0.01 recorded in Q3 2025.
- Pharma-Bio Serv's EPS (Weighted Average and Diluted)'s 5-year high stood at $0.1 during Q3 2021, with a 5-year trough of -$0.21 in Q4 2021.
- In the last 5 years, Pharma-Bio Serv's EPS (Weighted Average and Diluted) had a median value of $0.01 in 2021 and averaged -$0.0.
- Examining YoY changes over the last 5 years, Pharma-Bio Serv's EPS (Weighted Average and Diluted) showed a top increase of 22665.73% in 2021 and a maximum decrease of 345792.8% in 2021.
- Over the past 5 years, Pharma-Bio Serv's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.21 in 2021, then skyrocketed by 103.58% to $0.01 in 2022, then crashed by 127.23% to -$0.0 in 2023, then crashed by 3265.68% to -$0.07 in 2024, then skyrocketed by 88.41% to -$0.01 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.01 for Q4 2025, versus $0.01 for Q3 2025 and $0.0 for Q2 2025.